SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1.
Law JLM, Logan M, Joyce MA, Landi A, Hockman D, Crawford K, Johnson J, LaChance G, Saffran HA, Shields J, Hobart E, Brassard R, Arutyunova E, Pabbaraju K, Croxen M, Tipples G, Lemieux MJ, Tyrrell DL, Houghton M.
Law JLM, et al. Among authors: tyrrell dl.
Vaccine. 2021 Sep 24;39(40):5769-5779. doi: 10.1016/j.vaccine.2021.08.081. Epub 2021 Aug 26.
Vaccine. 2021.
PMID: 34481699
Free PMC article.